APOL1 and COVID-19: Our major conclusions from the present study are that several COVID-19–induced cytokines, beyond IFNs, act synergistically via JAK/STAT signaling to drive pathogenic APOL1 expression, resulting in podocyte injury and loss, which are blocked by JAK inhibition.